Australians with devastating cancers are living longer, thanks to genomics and advanced treatments, but many are being left behind

A landmark Australian report by Omico will be launched tomorrow (25^th Nov) at Parliament House showing that Australians with devastating cancer can have their lives extended when their tumour DNA is matched to advanced treatment, a process called precision oncology, which is simultaneously creating jobs and fuelling our economy.

Omico is Australia’s not for profit leader in precision oncology. It’s Impact Report: From Momentum to Mainstream shows:

• Australians matched to targeted treatment for their cancer lived up to 50% longer, from 14 to 21+ months, with survival more than doubling for some

• Omico initiatives have attracted more than $200 million to Australia, from direct foreign investment

• To date, Omico has created 1540+ new jobs, including in regional and Indigenous communities